enVVeno Medical Corporation

The momentum for this stock is not very good. enVVeno Medical Corporation is not very popular among insiders. enVVeno Medical Corporation is a mediocre stock to choose.

News

enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing

Accesswire MedTech Marketing Leader with Significant New Product Launch Experience for Cardiovascular DevicesKey Addition to Commercial Team as Company Begins Planning for the VenoValve MonetizationSeveral...\n more…

Head-To-Head Analysis: enVVeno Medical (NASDAQ:NVNO) versus CVRx (NASDAQ:CVRX)

Zolmax enVVeno Medical (NASDAQ:NVNO - Get Free Report) and CVRx (NASDAQ:CVRX - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies...\n more…

Analyzing enVVeno Medical (NASDAQ:NVNO) & CVRx (NASDAQ:CVRX)

Ticker Report enVVeno Medical (NASDAQ:NVNO - Get Free Report) and CVRx (NASDAQ:CVRX - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses...\n more…

Vanguard Group Inc. Buys 237,550 Shares of enVVeno Medical Corporation (NASDAQ:NVNO)

Zolmax Vanguard Group Inc. raised its position in shares of enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) by 70.6% in the first quarter, according to its most recent filing with the SEC. The firm...\n more…

enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)

Accesswire VenoValve PMA Approval Application Process Consists of the Submission of 5 Modules to the FDA4 Modules Have Now Been Submitted, Reviewed, and Approved by the FDACompany on Track to File the 5th and...\n more…

enVVeno Medical Corporation (NASDAQ:NVNO) Shares Purchased by Fermata Advisors LLC

Ticker Report Fermata Advisors LLC raised its position in enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) by 33.4% in the second quarter, according to the company in its most recent Form 13F filing with...\n more…